Calithera Biosciences Financials

Calithera Biosciences Stock Summary

Calithera Biosciences competes with Abeona Therapeutics, Affimed NV, Checkpoint Therapeutics, Adaptimmune Therapeutics, and Mereo BioPharma. Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California. Calithera Biosci operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 63 people.

Calithera Biosciences Key Financial Ratios

Calithera Biosciences' financial ratios allow both analysts and investors to convert raw data from Calithera Biosciences' financial statements into concise, actionable information that can be used to evaluate the performance of Calithera Biosciences over time and compare it to other companies across industries.

Calithera Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Calithera Biosciences's current stock value. Our valuation model uses many indicators to compare Calithera Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Calithera Biosciences competition to find correlations between indicators driving Calithera Biosciences's intrinsic value. More Info.Calithera Biosciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Calithera Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Calithera Biosciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Calithera Biosciences Market Pulse

Along with financial statement analysis, the daily predictive indicators of Calithera Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Calithera Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Calithera Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Calithera Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Calithera Biosciences's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

If you are still planning to invest in Calithera Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Calithera Biosciences' history and understand the potential risks before investing.